文献速递关节外科

初次全髋关节置换术后应何时进行全血细胞计数检查?

When Should Complete Blood Count Tests Be Performed in Primary Total Hip Arthroplasty Patients?
PubMed 文献 · J Arthroplasty · 2018-05-29

该回顾性研究纳入2012至2014年在单中心接受初次全髋关节置换术的352例患者,分析术后常规全血细胞计数的使用情况。54例(15.3%)接受输血,输血者术前血红蛋白12.0 g/dL显著低于未输血者13.5 g/dL(P < .001)。未使用氨甲环酸者输血可能性为使用者的3.7倍。术后血小板或白细胞计数结果未促使任何患者接受医疗干预。术前贫血或未使用氨甲环酸者,术后第1天血红蛋白低于11.94 g/dL可预测输血。

要点

  • 352例初次全髋置换患者中54例(15.3%)输血,输血者术前血红蛋白12.0 g/dL显著低于未输血者13.5 g/dL(P < .001)。
  • 未使用氨甲环酸的患者输血可能性是使用者的3.7倍。
  • 术前血红蛋白正常且使用氨甲环酸者,术后常规全血细胞计数不提供可操作信息;术前贫血或未用氨甲环酸者至少应在术后第1天查全血细胞计数。

核心结论

  • 在价值医疗模式下,控制成本同时维持高质量患者照护至关重要。
  • 术前血红蛋白正常且接受氨甲环酸的患者,术后常规全血细胞计数检查不贡献可操作信息。
  • 术前贫血或未接受氨甲环酸的患者,至少应在术后第1天进行全血细胞计数检查。

研究设计与样本

  • 回顾性综述,纳入2012至2014年在单中心接受初次全髋关节置换术的352例患者。
  • 收集术前和术后全血细胞计数数值、人口学数据、氨甲环酸使用情况及输血率。
  • 采用逻辑回归模型识别与术后实验室值异常及输血风险相关的因素。

主要发现

  • 352例患者中54例(15.3%)接受输血。
  • 输血患者术前血红蛋白为12.0 g/dL,显著低于未输血患者的13.5 g/dL(P < .001)。
  • 未接受氨甲环酸的患者接受输血的可能性是接受者的3.7倍。
  • 没有患者因术后血小板或白细胞计数结果而接受医疗干预。
  • 术前贫血或未接受氨甲环酸的患者,术后第1天血红蛋白低于11.94 g/dL可预测输血。

临床怎么用

  • 术前血红蛋白正常且接受氨甲环酸的患者,术后常规全血细胞计数检查不贡献可操作信息。
  • 术前贫血或未接受氨甲环酸的患者,至少应在术后第1天进行全血细胞计数检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Routine laboratory studies are often obtained following total hip arthroplasty (THA). Moreover, laboratory studies are often continued daily until the patient is discharged regardless of medical management. The purpose of this study was to investigate the use of routine complete blood count (CBC) tests following THA. Secondarily, the purpose was to identify patient factors associated with abnormal postoperative lab values. METHODS: This retrospective review identified 352 patients who underwent primary THA at a single institution from 2012 to 2014. Preoperative and postoperative CBC values were collected along with demographic data, use of tranexamic acid (TXA), and transfusion rates. Logistic regression models were used to identify factors associated with an abnormal postoperative lab and risk of transfusion. RESULTS: Of the 352 patients, 54 patients were transfused (15.3%). Patients who underwent transfusion had a significantly lower preoperative hemoglobin (Hb; 12.0 g/dL) compared to patients who did not undergo transfusion (13.5 g/dL; P < .001). Patients who did not receive TXA were 3.7 times more likely to receive a transfusion. No patients received medical intervention based on the outcome of postoperative platelet or white blood counts. A Hb value below 11.94 g/dL for patients who are anemic preoperative or did not receive TXA predicted transfusion after postoperative day 1. CONCLUSION: Under value-based care models, cost containment while maintaining high-quality patient care is critical. Routine postoperative CBC tests in patients with a normal preoperative Hb who receive TXA do not contribute to actionable information. Patients who are anemic before THA or do not receive TXA should at minimum obtain a CBC on postoperative day 1.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kildow BJ, Howell EP, Karas V, et al. When Should Complete Blood Count Tests Be Performed in Primary Total Hip Arthroplasty Patients? J Arthroplasty. 2018. PMID: 29908797. doi:10.1016/j.arth.2018.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。